Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation

被引:11
|
作者
Perez, Ariadna [1 ]
Montoro, Juan [2 ]
Hernani, Rafael [1 ]
Lorenzo, Ignacio [2 ]
Carlos Hernandez-Boluda, Juan [1 ,3 ]
Gimenez, Estela [4 ]
Dolores Gomez, Maria [5 ]
Balaguer-Rosello, Aitana [2 ]
Gonzalez-Barbera, Eva [5 ]
Guerreiro, Manuel [2 ]
Aguilar, Cristobal [2 ]
Navarro, David [3 ,4 ]
Solano, Carlos [1 ,3 ]
Sanz, Jaime [2 ,3 ,6 ]
Luis Pinana, Jose [2 ,6 ]
机构
[1] Fdn INCLIVA, Hosp Clin Univ, Dept Hematol, Valencia, Spain
[2] Hosp Univ & Politecn la Fe, Dept Hematol, Valencia, Spain
[3] Univ Valencia, Sch Med, Dept Med, Valencia, Spain
[4] Hosp Clin Univ, Microbiol Serv, Valencia, Spain
[5] Univ Valencia, Sch Med, Dept Microbiol, Valencia, Spain
[6] Inst Carlos III, CIBERONC, Madrid, Spain
关键词
allogeneic stem cell; community acquired respiratory virus; immunodeficiency scoring index; rhinovirus; trasplantation; HUMAN RHINOVIRUS INFECTIONS; INFLUENZA INFECTIONS; PARAINFLUENZA VIRUS; SYNCYTIAL VIRUS; RECIPIENTS; OUTCOMES; ADULTS; TRACT;
D O I
10.1111/tid.13301
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Enterovirus/rhinoviruses (EvRh) are the most common cause of respiratory virus infections in recipients of allogeneic stem cell transplantation (allo-HSCT). Objective We sought to analyze the value of the immunodeficiency scoring index (ISI) in predicting lower respiratory tract disease (LRTD) progression and mortality in a prospective cohort of consecutive adult (>16 years) allo-HSCT recipients with EvRh infection from December 1 2013 to December 1 2019 at two Spanish transplant centers. Results We included 234 allo-HSCT recipients with 383 EvRh episodes. Out of 383 EvRh episodes, 98 (25%) had LRTD. Multivariate logistic regression analysis identified three independent factors associated with LRTD progression: Ig G < 400 mg/dL, community-acquired respiratory virus (CARV) co-infection and high-risk ISI. Inclusion of Ig G levels and CARV co-infection in the ISI improved its performance by significantly increasing the area under the receiver operator characteristic curve (AUROC) from 0.643 to 0.734 (P = .03). Likewise, the two conditions identified by multivariate analyses as associated with higher probability of mortality were high-risk ISI and EvRh infection within 6 months after transplant. Conclusions Our findings confirm the value of high-risk ISI in predicting both probability of EvRh LRTD and 3-month overall mortality. We also demonstrate that the original ISI could be adapted to other CARV types by including additional variables to improve its performance.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Hepatic Safety of Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation
    Amigues, I.
    Cohen, N.
    Chung, D.
    Seo, S. K.
    Plescia, C.
    Jakubowski, A.
    Barker, J.
    Papanicolaou, Genovefa A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (01) : 46 - 52
  • [42] Fatal human metapneumovirus infection following allogeneic hematopoietic stem cell transplantation
    Dokos, C.
    Masjosthusmann, K.
    Rellensmann, G.
    Werner, C.
    Schuler-Luettmann, S.
    Mueller, K. -M.
    Schiborr, M.
    Ehlert, K.
    Groll, A. H.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (03) : E97 - E101
  • [43] Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation
    Balassa, Katalin
    Salisbury, Richard
    Watson, Edmund
    Lubowiecki, Marcin
    Tseu, Bing
    Maouche, Nadjoua
    Jeffery, Katie
    Misbah, Siraj A.
    Benamore, Rachel
    Rowley, Lara
    Barton, Daja
    Pawson, Rachel
    Danby, Robert
    Rocha, Vanderson
    Peniket, Andy
    JOURNAL OF INFECTION, 2019, 78 (06) : 461 - 467
  • [44] Development of the Japanese Version of the Psychosocial Assessment of Candidates for Transplantation in Allogeneic Hematopoietic Stem Cell Transplantation
    Harashima, Saki
    Yoneda, Ryo
    Horie, Takeshi
    Kayano, Mami
    Fujioka, Yosei
    Nakamura, Fumihiko
    Kurokawa, Mineo
    Yoshiuchi, Kazuhiro
    PSYCHOSOMATICS, 2017, 58 (03) : 292 - 298
  • [45] Nontuberculous mycobacterial bloodstream infections after allogeneic hematopoietic stem cell transplantation
    Nagata, Akihito
    Sekiya, Noritaka
    Najima, Yuho
    Horiuchi, Masao
    Fukushima, Kazuaki
    Toya, Takashi
    Igarashi, Aiko
    Kobayashi, Takeshi
    Kakihana, Kazuhiko
    Ohashi, Kazuteru
    Doki, Noriko
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 97 : 131 - 134
  • [46] Incidence of Clostridium difficile Infection in Patients with Acute Leukemia and Lymphoma after Allogeneic Hematopoietic Stem Cell Transplantation
    Leung, Sharon
    Metzger, Brian S.
    Currie, Brian P.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (03) : 313 - 315
  • [47] Community Respiratory Virus Infection in Hematopoietic Stem Cell Transplantation Recipients and Household Member Characteristics
    Sams, Kay A.
    Reich, Richard R.
    Boyington, Alice R.
    Barilec, Elsa M.
    ONCOLOGY NURSING FORUM, 2015, 42 (01) : 74 - 79
  • [48] Kaposi's sarcoma developed after allogeneic hematopoietic stem cell transplantation
    Ye, Xu
    Feng, Ying
    Pang, Ying
    Liu, Yanhui
    Lin, Suxia
    ONCOLOGY LETTERS, 2011, 2 (03) : 515 - 518
  • [49] Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation
    Gazourian, Lee
    Coronata, Anna Maria F.
    Rogers, Angela J.
    Weinhouse, Gerald L.
    Soiffer, Robert J.
    Antin, Joseph H.
    Ritz, Jerome
    Ho, Vincent T.
    Baron, Rebecca M.
    Washko, George R.
    RESPIRATORY MEDICINE, 2013, 107 (02) : 276 - 283
  • [50] Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation
    Khanna, N.
    Steffen, I.
    Studt, J. -D.
    Schreiber, A.
    Lehmann, T.
    Weisser, M.
    Flueckiger, U.
    Gratwohl, A.
    Halter, J.
    Hirsch, H. H.
    TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (02) : 100 - 105